Haoxi Health Technology Ltd
Company Information
Industry
Services-Advertising Agencies
SIC Code
7311
Entity Type
other
SEC Category
Non-accelerated filerEmerging growth company
State of Incorporation
Cayman Islands
Country
China
Business Address
801/802, TOWER C, BUILDING 103, BEIJING, , 100101
Mailing Address
801/802, TOWER C, BUILDING 103, BEIJING, , 100101
Phone
86-10-13311587976
Fiscal Year End
0630
EIN
000000000
Financial Overview
FY2025
$21.60M
Total Assets
$1.66
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 3 Initial insider ownership report | March 19, 2026 | View on SEC |
| 6-K Foreign company current report | March 6, 2026 | View on SEC |
| 6-K Foreign company current report | February 10, 2026 | View on SEC |
| 424B5 Prospectus supplement | January 23, 2026 | View on SEC |
| 6-K Foreign company current report | January 23, 2026 | View on SEC |
| 6-K Foreign company current report | December 10, 2025 | View on SEC |
| 6-K Foreign company current report | December 3, 2025 | View on SEC |
| 6-K Foreign company current report | November 12, 2025 | View on SEC |
| 6-K Foreign company current report | October 24, 2025 | View on SEC |
| 20-F Foreign company annual report | October 20, 2025 | View on SEC |
Annual Reports
20-F
October 20, 2025
- Became a leader in China’s booming healthcare ad market (especially short videos).
- Kept 85%+ clients in healthcare – smart focus as China’s population ages.
Related Companies
Companies in the same industry (SIC: 7311)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.